[Current views on the mode of action of hypoglycemic sulfonamides].
D000596:Amino Acids / Q000008:administration & dosage; D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D002747:Chlorpropamide / Q000627:therapeutic use; D003919:Diabetes Insipidus / Q000188:drug therapy; D003921:Diabetes Mellitus, Experimental; D004231:Diuresis / Q000187:drug effects; D004357:Drug Synergism; D005934:Glucagon / Q000037:antagonists & inhibitors / Q000378:metabolism; D005947:Glucose / Q000378:metabolism; D005951:Glucose Tolerance Test; D006801:Humans; D006852:Hydrochlorothiazide / Q000494:pharmacology; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000494:pharmacology*; D007275:Injections, Intravenous; D007328:Insulin / Q000097:blood / Q000378:metabolism; D000078790:Insulin Secretion; D008099:Liver / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism; D011817:Rabbits; D051381:Rats; D013449:Sulfonamides / Q000009:adverse effects / Q000494:pharmacology*; D014044:Tolbutamide / Q000008:administration & dosage
D000596:Amino Acids; D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D013449:Sulfonamides; D006852:Hydrochlorothiazide; D005934:Glucagon; D014044:Tolbutamide; D005947:Glucose; D002747:Chlorpropamide